Log in
Enquire now
Editas Medicine

Editas Medicine

Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.

OverviewStructured DataIssuesContributors

Contents

editasmedicine.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Induced pluripotent stem cell
Induced pluripotent stem cell
Therapeutics
Therapeutics
Genetic engineering
Genetic engineering
Healthcare
Healthcare
CRISPR
CRISPR
...
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Boulder, Colorado
Boulder, Colorado
Colorado
Colorado
0
B2X
B2B
B2B
0
B2C
B2C
CEO
‌
GILMORE O’NEILL, M.B.
0
Founder
J. Keith Joung
J. Keith Joung
0
‌
Jennifer Doudna
Feng Zhang
Feng Zhang
George Church
George Church
Jennifer Doudna
Jennifer Doudna
AngelList URL
angel.co/company/editas
Pitchbook URL
pitchbook.com/profiles.../60465-97
Legal Name
Editas Medicine, Inc.0
Legal classification
Corporation
Corporation
Public company
Public company
Date Incorporated
2013
Number of Employees (Ranges)
201 – 5000
Email Address
info@editasmed.com0
patients@editasmed.com0
ir@editasmed.com0
careers@editasmed.com0
cristi.barnett@editasmed.com0
Phone Number
+161740190520
+161740101330
+16174019000
Number of Employees
2640
Full Address
4909 Nautilus Court North Suite 208/211 Boulder, CO 803010
11 Hurley Street Cambridge, MA 02141 United States0
CIK Number
1,650,6640
Place of Incorporation
Delaware
Delaware
0
Investors
EcoR1 Capital
EcoR1 Capital
Fidelity Investments
Fidelity Investments
Khosla Ventures
Khosla Ventures
T. Rowe Price
T. Rowe Price
Jennison Associates
Jennison Associates
Google Ventures
Google Ventures
Partners Innovation Fund
Partners Innovation Fund
Viking Global Investors
Viking Global Investors
...
DUNS Number
0793289550
IRS Number
464,097,5280
Founded Date
2013
Total Funding Amount (USD)
656,600,000
Latest Funding Round Date
January 2021
Competitors
Exuma Biotechnology
Exuma Biotechnology
Pathway Genomics
Pathway Genomics
Stock Symbol
EDIT0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
David Scadden
0
‌
James Mullen
0
‌
GILMORE O’NEILL, M.B.
0
‌
emma reeve
0
Andrew Hirsch
Andrew Hirsch
0
CFO
‌
Michelle Robertson
0
Former CEO
‌
Cynthia Collins
Latest Funding Type
Series B
Series B
CAGE Code
76VR50
Patents Assigned (Count)
16
Wellfound ID
editas
Technologies Used
CRISPR
CRISPR
Country
United States
United States
0
Headquarters
Cambridge, Massachusetts
Cambridge, Massachusetts
0

Other attributes

Company Operating Status
Active
SIC Code
2,8360
Ticker Symbol
EDIT
Wikidata ID
Q23131313

Editas Medicine is a biotechnology and synthetic biology company using genetic engineering to create therapeutics for treating disease. It is headquartered in Cambridge, Massachusetts, and was founded in 2013 by Feng Zhang, J. Keith Joung, and Jennifer A. Doudna.

Editas Medicine has developed a proprietary genome editing platform based on CRISPR using different engineered variants of CRISPR effector nucleases Cas9 and Cpf1 (also known as Cas12a). The company is working on gene editing efficiency and delivery of treatment to the sight of disease. Editas Medicine is in the discovery stage of developing CRISPR gene edit treatments for the following conditions:

Leber Congenital Amaurosis 10

Usher Syndrome 2a

HSV-1

T Cells for cancer treatments

Beta Thalassemia

Sickle Cell

Cystic Fibrosis

Alpha-I Antitrypsin Deficiency

Editas Medicine was previously founded under the name Gengine by Feng Zhang, George Church, Keith Joung, David Liu all from The Broad Institute at MIT and Harvard along with Jennifer Doudna from the University of California, Berkeley. Jennifer Doudna left and co-founded Intellia Therapeutics.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Editas Medicine

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.